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Summary 
A study was made on the clinical and biochemical features of siblings of 
patients with hyperchylomicronemia and its inherited relationship. It was not 
a case of the classical type of familial LPL deficiency, but of familial apolipo- 
protein C-II deficiency. The first patient with apolipoprotein C-II deficiency 
was reported by Breckenridge et al. and our patients provide the basis for the 
second report of this new disease. Our observations in this study strongly 
suggest that familial apolipoprotein C-II deficiency is transmitted by an auto- 
somal recessive mode of inheritance and heterozygotes of this disorder have no 
abnormalities of plasma lipid and lipoproteins in spite of the reduced plasma 
apolipoprotein C-II. 
Key words: Apolipoproteins - Chylomicrons - Familial hyperlipoproteinemia - Genetic 
disease -Lipoprotein lipase -Lipoproteins 
Introduction 
Familial type I hyperlipoproteinemia is a rare disease characterized by an 
extreme increase of chylomicrons in the serum [l]. The biochemical defect of 
this disease has been thought to be an impaired clearance of chylomicrons 
because of deficiency of lipoprotein lipase (LPL) which catalyzes the hydrol- 
ysis of triglyceride-rich lipoproteins [ 1,2]. LPL localizes on the surface of 
* Present address: The Department of Pathological Science. Research Institute, National Cardiovascular 
Center, 5-125. Fujishiro-dai. Suita-shi. Osaka&, 565 Japan. 
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capillary endothelium and requires a cofactor for its activity, apolipoprotein 
C-II [ 3-61, which is present in serum. The enzyme is released into plasma by 
intravenous injection of heparin. Postheparin plasma also contains another 
lipolytic enzyme, hepatic triglyceride lipase (H-TGL) [7,8], but only LPL 
activity is usually deficient in postheparin plasma from patients with familial 
type I hyperlipoproteinemia [ 91. 
Recently, Breckenridge et al. [lo] reported a patient with hypertriglycer- 
idemia associated with deficiency of apolipoprotein C-II. The patient, a 59- 
year-old male, had clinical and biochemical features similar to type I hyperlipo- 
proteinemia and apparently had LPL deficiency. In his own postheparin 
plasma, however, LPL was actually present, and only an activator for it - apo 
C-II -was absent. 
In this paper, we describe two cases (a brother and a sister) of familial hyper- 
chylomicronemia caused by apo C-II deficiency; the second case of Brecken- 
ridge-type hyperlipoproteinemia, with special reference to the genetic aspect of 
this new inherited disorder. 
Case Report 
The patients, siblings, are a 13-year-old Japanese girl (H.T.) and a 15-year-old 
boy (K.T.) who were referred to our lipid clinic of Osaka University Hospital 
because of serum turbidity. They were born to a consanguineous marriage and 
their parents were first cousins (Fig. 1). The patients had never experienced 
abdominal pain or diarrhea. They both were usually in good health and asymp- 
tomatic. Physical examination revealed well developed children. Neither hepato- 
splenomegaly nor xanthomas were observed. The tonsils were slightly enlarged 
but not pathological. The results of the laboratory examination are summarized 
in Table 1. They were unremarkable with the exception of very high serum 
triglyceride levels and a slightly elevated ASLO. Liver function tests and serum 
protein electrophoresis were normal. Fasting blood sugar was in the normal 
range and oral GTT revealed normal insulin and glucose responses. There was 
no sign of thyroid dysfunction. Serum triglyceride concentrations in H.T. and 
K.T. were 1094 mg/dl and 1090 mg/dl, and cholesterol 161 mg/dl and 204 
mg/dl, respectively, on a mild fat-restricted diet. Family screening was carried 
I 
I 
t T-- 
lv 
Fig. 1. T kindred. family tree. 
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TABLE 1 
LABORATORY MEASUREMENTS OF H.T. AND K.T. 
H.T. K.T. 
Urinalysis 
Protein 
Sugar 
(-_) 
(-1 
(-_) 
(-_) 
Blood analysis 
RBC (X104/mm3) 
Hb (g/dI) 
Ht (%) 
WBC (/mm3) 
504 476 
14.6 13.6 
40.2 37.9 
5200 4100 
Serum chemistry 
h’a Whll) 
K GuEs/N 
Cl 01Esb) 
Urea nitrogen (mg/dI) 
Uric acid (mg/dl) 
Amylase (Somogyi U) 
Total protein (g/dI) 
Protein electrophoresis 
Albumin (a) 
(Y 1 -Globulin (96) 
aZ-Globulin (%) 
P-Globulin (%) 
‘y-Globulin (I) 
Cholesterol (mg/dl) 
Triglycerides (mg/dI) 
ZTT (U) 
GOT (U) 
GPT (U) 
Alkaline phosphatase (K.A.U.) 
y-GTP (mu/ml) 
T4 olg/dI) 
137 137 
4.6 4.1 
96 98 
16.2 16.2 
4.2 3.7 
15 84 
7.6 7.5 
67.2 69.2 
3.1 2.7 
8.9 8.8 
6.4 6.8 
14.0 12.2 
161 204 
1094 1090 
12 9 
20 18 
8 6 
34.9 24.1 
2 2 
7.0 6.3 
Serological test 
CRP 
ASLO (T.U.) 
RA 
(-_) 
240 
(-) 
C-1 
160 
(-) 
0-GTT (100 g glucose) Bsa IRI b asa IRI b 
0 (min) 82 16 80 11 
30 119 41 119 24 
60 93 33 103 27 
90 93 20 98 16 
120 93 25 102 17 
180 62 11 89 6 
a Blood sugar (mg/dI); b immunoreactive insulin &U/ml). 
out for the parents and another sibling. The clinical and biochemical chara&er- 
istics of the members of this family are listed in Table 2. 
Material8 and Methods 
For preparative ultracentrifugation, blood samples were collected into 
EDTA-2Na (1 mg/ml) following an overnight fast. Plasma was separated 
promptly after low-speed centrifugation at room temperature and kept at 4°C 
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until analysis. Other studies were performed on blood serum unless otherwise 
indicated. 
Lipids were extracted with chloroform-methanol according to the method of 
Folch et al. [ 111. Cholesterol was determined by the method of Zurkowski 
[ 121 and phospholipid was obtained by a modification of the method of Cahn 
et al. [ 131. Triglycerides were determined by periodate oxidation and reaction 
with acetylacetone following treatment of the serum with Zeolite [14]. The 
amount of total apoproteins in the lipoprotein fractions was determined by the 
method of Lowry et al. [ 151, using crystalline bovine serum albumin as a 
standard. Reaction mixtures were extracted twice with chloroform after color 
development. 
The plasma lipoproteins were analyzed using a combination system of poly- 
acrylamide gel electrophoresis (PAGE), preparative ultracentrifugation and 
heparin-manganase precipitation. PAGE was performed on Sudan Black 
B-prestained serum samples using a 3.0% running gel for lipoprotein separation 
by the method of Narayan et al. [ 161. Lipoprotein patterns were obtained by 
densitometric scanning with a densitometer (Fuji FD-A-IV). 
Quantitative ultracentrifugation was carried out in a Hitachi model 55P-7 
ultracentrifuge using a RP-40 rotor head according to the method of Hatch and 
Lee [ 171. Plasma samples were centrifuged at 25,000 rpm for 25 min in order 
to separate chylomicrons. Very low density lipoprotein (VLDL, d < 1.006) was 
isolated in the top fraction from chylomicron-free plasma after 18 h of ultra- 
centrifugation at 40,000 rpm in a solvent with a density of 1.006. The heparin- 
manganase precipitation method [ 181 was used to precipitate low density lipo- 
protein (LDL) from the bottom fraction (d > 1.006) of the last ultracentrifuga- 
tion and high density lipoprotein (HDL) was obtained as the supernatant. The 
concentrations of cholesterol and triglyceride were measured in each of these 
lipoprotein fractions. 
Tetramethylurea (TMU)-soluble apolipoproteins in chylomicrons and VLDL 
were analyzed by PAGE according to the method of Kane [19] with a minor 
modification. Washed chylomicrons or VLDL preparations containing approxi- 
mately 60-100 pg of total protein were mixed with TMU. After delipidation, 
an aqueous solution of Bromophenol Blue (BPB) was added as an indicator to 
each preparation. Electrophoresis was carried out using a 7.5% running gel con- 
taining 6 M urea. Gels were stained by Amido Black 10B for 30 min and 
destained in 7% acetic acid solution followed by densitometer scanning. The 
relative concentration of apo C-II in VLDL was determined as the ratio of the 
scanned area of apo C-II peak to that of apo C-III peaks (C-III-1 plus C-111-2) 
in densitometric scanning of electrophoretograms of TMU-soluble apo-VLDL. 
Apo C-II was isolated by the following procedures. TMU-soluble apo-VLDLs 
from patients with hypertriglyceridemia were separated by electrophoresis on 
large preparative polyacrylamide gels and visualized under ultraviolet light after 
staining with the magnesium salt of 8-anilino-1-naphthalene sulfonic acid in 
saturated (NH4)$04 [ 201. The fluorescent bands of apo C-II were cut out and 
extracted with water. The extract containing apo C-II was dialyzed and 
lyophilized. 
Postheparin plasma was obtained at 10 min after intravenous injection of 
sodium heparin (0.1 mg/kg body weight) after an overnight fast. Samples were 
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collected into tubes containing 0.1 ml of 0.1 M sodium citrate per ml. The 
plasma was separated by low-speed centrifugation at 4°C. Postheparin lipolytic 
activity (PHLA) was determined by the modified method of Okuda et al. [ 211. 
The assay system consisted of 0.05 ml of 1 : 4 diluted Ediol, 0.45 ml of 0.1 M 
Tris-HCl buffer pH 9.0 containing 5% (w/v) bovine serum albumin (Fraction V) 
with or without -2 M NaCl (final concentration 0.9 M) and 0.5 ml of diluted 
postheparin plasma. When serum or apo C-II was added to the assay mixture as 
an activator, 0.25 ml of postheparin plasma and 0.25 ml of serum or apo C-II in 
saline were used instead of diluted postheparin plasma. After incubation for 1 h 
at 37”C, released free fatty acids (FFA) were extracted and titrated by the 
method of Dole [ 221. The results were expressed as PEq of released FFA/ml of 
postheparin plasma/h. The activity obtained in high-salt buffer corresponded to 
the activity of H-TGL [ 7,8]. The activity of LPL was calculated by subtracting 
the value of H-TGL from the total activity obtained in low-salt conditions. 
The ability of human serum to activate guinea pig lipoprotein lipase was 
measured according to the method of Chu et al. [23]. The guinea pig blood 
samples were withdrawn after 4 min following the intracardiac injection of 
sodium heparin (20 U/kg body weight). Guinea pig postheparin plasma and 
human sera obtained from members of the T family and from healthy normo- 
lipidemic volunteers were stored at -10°C until use. Lipolytic activity of 
guinea pig postheparin plasma showed a linear increase in proportion to the 
amount of standard human serum added to the assay mixture at least up to 
0.6 ml. Accordingly, the assay was carried out after addition of 0.4 ml of test 
serum. The activity was expressed arbitrarily as units percent of a standard 
serum after subtraction of basal lipolytic activity of guinea pig postheparin 
plasma. 
Results 
Serum lipids, lipoproteins and apolipoproteins 
The serum lipid levels and the lipid composition of lipoproteins in members 
of the T family are summarized in Tables 2 and 3. In patients H.T. and K.T. 
serum triglyceride concentrations were very high, 1094 mg/dl and 1090 mg/dl, 
TABLE 3 
LIPOPROTEIN LIPID CONCENTRATIONS IN THE PATIENTS AND THEIR PARENTS 
Subject Cholesterol (mg/dI) Triglycerides (mg/dl) 
Total Chylo. a VLDL LDL c HDL c Total Chylo. a VLDL LDL + HDL b 
Patient H.T. 161 9s 35 12 16 1094 813 219 62 
Patient K.T. 204 119 45 23 17 1090 823 198 69 
Father 174 - 2 129 43 58 - 10 48 
Mother 176 - 21 106 50 128 - 67 61 
a Chylomicrons. 
b Bottom fractions Isolated by ultracentrifugation at d = 1.006 from cbylomicron-free plasma. 
c Isolated by heparin-manganese precipitation method from ultracentrifugal bottom fraction at d = 1.006. 
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respectively, but serum cholesterol levels were within the normal range, 161 
mg/dl and 204 mg/dl, on a mild fat-restricted diet. The lipoprotein pattern on 
PAGE revealed a high chylomicron peak in each patient but normal patterns 
were obtaihed from other relatives (Fig. 2). By ultracentrifugal analysis, more 
than 80% of plasma triglycerides were recovered in the chylomicron fraction 
from each patient. The amount of cholesterol in this fraction was 98 mg/dl in 
H.T. and 119 mg/dl in K.T., corresponding to more than half the value for total 
plasma cholesterol. However, HDL- and LDL-cholesterol were markedly 
reduced, 12 mg/dl and 16 mg/dl in H.T., and 23 mg/dl and 17 mg/dl in K.T., 
respectively. In contrast, the parents and an elder sister had completely normal 
serum lipid and lipoprotein levels. 
The densitometric pattern of apolipoproteins in the chylomicron fractions is 
shown in Fig. 3. The C apoproteins are clearly separated into C-I, C-II, C-III-1 
and C-III-2 on PAGE [ 191, as shown in the control. In our PAGE system, the 
Rf values for apo C-II, apo C-III-1 and apo C-III-2 (with BPB band as a refer- 
ence) were 0.52-0.54, 0.60-0.62 and 0.66-0.68, respectively. In contrast to 
the control, apo C-II band was not detected in chylomicron apoproteins 
obtained from patient K.T. (Fig. 3). The same result, not shown in the figure, 
was obtained for VLDL apoprotein in this patient. The lack of apo C-II on 
PAGE was also observed in triglyceride-rich lipoproteins from patient H.T. On 
the other hand, the apo C-II band was clearly observed on PAGE of apo-VLDL 
in their parents. However, the relative concentration of their apo C-II was 
reduced, approximately 50% of the mean control value (Table 4). 
Patient K.T. 
h I 
Mother 
Ch 182 
TG 228 Contrd 
Fig. 2. Densitometric patterns of polyacrylamide gel electrophoresis of serum lipoproteins in patient H.T. 
(upper) and her mother (lower). The pattern in patient K.T. was similar to that in XT.. and patients’ 
father and sister, to that in their mother. 
Fig. 3. Densitometric patterns of polyacrylamide gel electrophoresis of TMU-soluhle apoproteins in chvlo- 
microns from patient K.T. (upper) and from a control subject with hyperchylomicronemia Praviously 
clasdfied as LPL deficiency (lower). @(upper panel) indicates the position of apoprotein C-II Peak. if 
present, judged by the Rf value. 
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TABLE 4 
RELATIVE CONCENTRATION OF APOLIPOPROTEIN C-II IN VLDL FROM MEMBERS OF THE T 
FAMILY AND CONTROL SUBJECTS 
Subject Ratio of APO C-II * 
Apo-C-III 
% of control value 
Patient H.T. 0 0 
Patient K.T. 9 0 
Father 0.19 48 
Mother 0.17 43 
Controls 0.40 i 0.10 b 100 
* Calculated from areas of densitometric peaks. See text. 
b Mean f SD for 5 normolipidemic healthy subjects. 
Postheparin lipolytic activity 
As familial type I hyperlipoproteinemia was strongly suggested in these 
patients by the lipid and lipoprotein analyses, LPL and H-TGL activities were 
measured using selective ‘NaCl inactivation in the postheparin plasma. In both 
patients (H.T. and K.T.) LPL activities were markedly decreased. Furthermore, 
H-TGL activities were also significantly lower than normal (Fig. 4). Their 
parents and elder sister, however, had normal LPL with subnormal or normal 
H-TGL activities (Fig. 4). When the serum from normolipidemic subjects was 
added to the assay mixture for PHLA, as shown in Methods, LPL activity 
markedly increased into or above the normal range (Fig. 5). H-TGL was not 
activated by normal serum. Activation of LPL by human serum was not 
observed in their parents and other hyperlipidemic subjects. When purified apo 
C-II (15 pg) was added to the assay mixture in place of whole serum, LPL 
activity increased approximately to the same extent (Fig. 5). 
H-TGL LPL 
rrbFFAh4.h uEaFFAh!hr 
5‘ i0 
Serum Lipids 
WI 
TG Ch. 
633 125 
315 119 
1374 186 
755 196 
81 199 
147 206 
75 207 
Fig. 4. Postheparin lipolytic activity and serum lipid concentrations in patients and their relatives. Each 
assay was performed as described in Methods. Both patients were examined before (HT. -1 and K.T. -1) 
and after (HT. -2and K.T. -2) a low-fat diet. Serum lipid concentrations were measured in blood samples 
obtained before heparln injection. Shaded areas represent the normal range (mean f SD). 
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Patient 
H.T 
K.T 
Father 
Mother 
Control 
Fig. 5. Lipoprotein lipase and hepatic triglyceride lipase activities in postheparln plasma from patients 
estimated after the addition of normal serum or purified apo C-II to the assay mixture. 0.26 ml of serum 
from a normolipidemic subject or 15 ~g of apo C-II were added to the assay mixture. Experiments were 
carried out as shown in the text. Shaded areas represent the normal range (mean k SD). 
Fig. 6. The levels of lipase activator in the serum of patients and their parents. Results are expressed in 
arbitrary units percent of the value obtained for a standard serum after subtraction of basal lipolytic 
activity of guinea pig postheparin plasma. Assay was performed twice in the same serum samples against 
different guinea pig postheptin plasma in the parents. Control subjects are six healthy volunteers without 
hyperllpoproteinemia. 
The LPL activator assay 
Since there is no activator for LPL in guinea pig postheparin plasma [24], 
triglycerides cannot be hydrolyzed unless rat or human serum is added [ 26,261. 
The activating ability of sera from patients and their parents was determined as 
lipolytic activity when a constant volume (0.4 ml) of test serum was added to 
the assay system. In contrast to the healthy control, serum from the patients 
(H.T. or K.T.) did not activate guinea pig LPL, as shown in Fig. 6. Further- 
more, serum from the parents showed approximately only 60% of the control 
activation ability value, 105 ? 13 U (Fig. 6). 
Discussion 
Our patients (H.T. and K.T.) had once been thought to have familial type I 
hyperlipoproteinemia (familial LPL deficiency), because they have heavy 
chylomicronemia and an apparent deficiency of LPL shown by routine PHLA 
activity. Hyperlipoproteinemia secondary to systemic lupus erythematosus, 
diabetes mellitus, hypothyroidism or paraproteinemia, was ruled out by 
physical and laboratory examinations. Apoprotein analysis of triglyceride-rich 
lipoproteins demonstrated the lack of apo C-II in both our patients, whereas 
apo C-II is one of the major apoproteins in triglyceride-rich lipoproteins from 
normal subjects. Apo C-II has been detected in those other cases of type I 
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hyperlipoproteinemia with LPL deficiency (Fig. 3). The functional role of the 
various apolipoproteins has not until now been completely understood. How- 
ever, it is well known that apo C-II is an important activator for LPL [3-6]. 
Although a marked reduction in LPL activity was observed by the standard 
assay procedure of PHLA, where postheparin plasma is used as an enzyme 
source as well as a sole source of the activator, activity completely recovered 
after addition of normal serum or purified apo C-II. 
These observations indicate that the patients H.T. and K.T. are not really 
deficient in LPL and that the cause of their chylomicronemia is a deficiency in 
its activator. On the other hand, patients with typical type I hyperlipoprotein- 
emia show a real deficiency of LPL in postheparin plasma [9] as well as in 
adipose tissue [ 271. This means that LPL activity cannot further increase after 
addition of normal serum or apo C-II [9,28]. Chylomicron triglycerides in our 
patients with familial apo C-II deficiency were not hydrolyzed by LPL - inac- 
tivated by the lack of an activator - so that the chylomicronemia appeared the 
same as in the classical type of familial LPL deficiency. 
The analysis of apoproteins in HDL was not performed in this study. How- 
ever, based upon the observation that the serum from the patients failed to 
activate LPL in guinea pig postheparin plasma (Fig. 6), it can easily be 
presumed that the same deficiency of apo C-II is present in HDL as in chylo- 
microns and VLDL, because the C apolipoproteins are interchangeable between 
triglyceride-rich lipoproteins and HDL in the process of lipoprotein metabolism 
1291. 
Recently Breckenridge et al. [lo] have described a 59-year-old male with 
severe hypertriglyceridemia caused by the absence of apo C-II and suggested 
his disease be called apolipoprotein C-II deficiency. Our patients have a hyper- 
lipoproteinemia with a biochemical defect similar to Breckenridge’s patient. 
But our patients have never suffered from xanthomas, pancreatitis or diabetes 
mellitus. The presence of diabetes mellitus, which is not a common complica- 
tion of familial LPL deficiency, must have aggravated the clinical features of the 
case of Breckenridge et al. Serum triglyceride concentrations in our patients 
were usually less than 2500 mg/dl, and relatively lower than the value of 
Breckenridge’s patient or of subjects with typical familial LPL deficiency 
reported by American and European authors. The regular diet in Japan is com- 
paratively low in fat and calories compared with that in Western countries and 
it is, therefore, suggested that pancreatitis and xanthomas did not develop in 
our patients because of the relatively low serum triglyceride levels. Youth may 
also have been a contributory factor. 
Most cases of reported familial LPL deficiency have normal H-TGL activity 
in postheparin plasma [9]. However, moderately reduced H-TGL activities were 
obtained for both our patients, in agreement with the data for the first patient 
with apo C-II deficiency. Reduced H-TGL activity is frequently observed in 
subjects with hypertriglyceridemia [30]. The physiological role of H-TGL is 
at present not well known. As the recovery of H-TGL activity was obtained in 
patient H.T. following reduced serum triglyceride concentration on a low-fat 
diet (Fig. 4), the decrease in H-TGL seems to be a secondary phenomenon. 
Furthermore, there is a possibility that abnormal H-TGL or inhibitors of 
H-TGL may have been present in the patients’ postheparin plasma, for 
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example, an inactive form of LPL in the absence of apo C-II. Ganesan et al. 
[31] described another LPL (LPL,,) in human postheparin plasma which 
requires apo C-I as an activator instead of apo C-II, and showed that LPLc.i 
activity was absent in postheparin plasma from type I hyperlipoproteinemia. 
In our patients’ sera the band corresponding to apo C-I was detected on PAGE 
(Fig. 4), although the assay of LPLc_r was not performed in this study. 
The parents had normal lipid concentrations and are first cousins. Two of 
their three children (one of each sex) have been affected with hyperchylo- 
micronemia. Thus, it is strongly suggested that the disorder is inherited as an 
autosomal recessive mode. It is reasonable to presume that some members of 
the kindred, including the parents of the patients, must have carried a single 
mutant allele to become heterozygotes. The consanguineous marriage of 
heterozygotes could give rise to the birth of homozygotes (patients H.T. and 
K.T.) bearing two mutant alleles. 
The LPL activator assay carried out in this study is thought to indicate only 
the net LPL activating power of the serum and not the exact amount of apo 
C-II itself, because apo C-III [5,32] and apo E [33,34] which reportedly 
inhibit LPL are also present in the same serum. Nevertheless, assuming that the 
level of LPL activating power obtained here correlates with the apo C-II level in 
serum, it can be postulated that apo C-II levels in the parents’ sera were 
reduced to approximately half the mean control value (Fig. 6); this strongly 
suggests that the parents were heterozygotes. This consideration is also sup- 
ported by the relative concentration of apo C-II in VLDL (Table 4). 
The parents were normolipidemic and had almost normal LPL activity in 
postheparin plasma, which was not increased by the addition of normal serum. 
These results indicate that the heterozygote for familial apo C-II deficiency has 
a decreased apo C-II level in his plasma but the amount is enough to activate 
LPL for hydrolysis of chylomicrons, while the homozygote with no detectable 
apo C-II suffers from hyperchylomicronemia. Our view of the heterozygote is 
supported by the observation of Breckenridge et al. that the plasma triglyceride 
level fell dramatically in a patient with apo C-II deficiency when the apo C-II 
concentration in his VLDL reached only 5-10s of its normal value after infu- 
sion of normal plasma [lo]. 
Addendum 
After this manuscript was completed, Cox et al. [35] reported that apo C-II 
deficiency is inherited as an autosomal recessive trait. This conclusion was 
based on a study of the relatives of Breckenridge’s patient with apo C-II defi- 
ciency. Seven homozygotes and ten heterozygotes for the disease were found in 
the same kindred. Our observations concerning inheritance of the disease 
agrees well with Cox et al. 
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